Agenus Inc., a clinical-phase biotechnology company, discovers and develops therapies to activate your body's immune method versus most cancers and bacterial infections in the United States and internationally. It offers Retrocyte Display, an antibody expression platform with the identification of entirely human and humanized monoclonal antibodies;